1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acid beta-Glucosidase Deficiency

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Acid beta-Glucosidase Deficiency in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radin, NS1
Bieberich, E; Freischütz, B; Suzuki, M; Yu, RK1

Reviews

1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acid beta-Glucosidase Deficiency

ArticleYear
Treatment of Gaucher disease with an enzyme inhibitor.
    Glycoconjugate journal, 1996, Volume: 13, Issue:2

    Topics: Animals; Cells, Cultured; Enzyme Inhibitors; Fishes; Gaucher Disease; Glucosylceramidase; Humans; Mice; Morpholines; Rats

1996

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Acid beta-Glucosidase Deficiency

ArticleYear
Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
    Journal of neurochemistry, 1999, Volume: 72, Issue:3

    Topics: 1-Deoxynojirimycin; Animals; Apoptosis; Brain Neoplasms; Cell Death; Cell Division; Ceramides; Enzyme Inhibitors; Gaucher Disease; Glucosylceramides; Glucosyltransferases; Glycolipids; Mice; Morpholines; Neuroblastoma; Rats; Tumor Cells, Cultured

1999